6P7N

Cryo-EM structure of LbCas12a-crRNA: AcrVA4 (2:2 complex)

これはPDB形式変換不可エントリーです。

6P7N の概要

• エントリーDOI: 10.2210/pdb6p7n/pdb
• EMDBエントリー: 20266 20267
• 分子名称: anti-CRISPR VA4, Cas12a, mature crRNA, ... (4 entities in total)
• 機能のキーワード: crispr-cas, anti-crispr, cas12a, cpf1, lbcas12a, acrva4, rna binding protein-rna complex, rna binding protein/rna
• 由来する生物種: Moraxella bovoculi; 詳細
• タンパク質・核酸の鎖数: 6
• 化学式量合計: 369332.55

構造登録者

Knott, G.J.,Liu, J.J.,Doudna, J.A. (登録日: 2019-06-06, 公開日: 2019-08-21, 最終更新日: 2023-08-16)

主引用文献

Knott, G.J.,Cress, B.F.,Liu, J.J.,Thornton, B.W.,Lew, R.J.,Al-Shayeb, B.,Rosenberg, D.J.,Hammel, M.,Adler, B.A.,Lobba, M.J.,Xu, M.,Arkin, A.P.,Fellmann, C.,Doudna, J.A.
Structural basis for AcrVA4 inhibition of specific CRISPR-Cas12a.
Elife, 8:-, 2019

PubMed Abstract: CRISPR-Cas systems provide bacteria and archaea with programmable immunity against mobile genetic elements. Evolutionary pressure by CRISPR-Cas has driven bacteriophage to evolve small protein inhibitors, anti-CRISPRs (Acrs), that block Cas enzyme function by wide-ranging mechanisms. We show here that the inhibitor AcrVA4 uses a previously undescribed strategy to recognize the Cas12a (LbCas12a) pre-crRNA processing nuclease, forming a Cas12a dimer, and allosterically inhibiting DNA binding. The Cas12a (AsCas12a) enzyme, widely used for genome editing applications, contains an ancestral helical bundle that blocks AcrVA4 binding and allows it to escape anti-CRISPR recognition. Using biochemical, microbiological, and human cell editing experiments, we show that Cas12a orthologs can be rendered either sensitive or resistant to AcrVA4 through rational structural engineering informed by evolution. Together, these findings explain a new mode of CRISPR-Cas inhibition and illustrate how structural variability in Cas effectors can drive opportunistic co-evolution of inhibitors by bacteriophage.

PubMed: 31397669
DOI: 10.7554/eLife.49110

実験手法

ELECTRON MICROSCOPY (4.9 Å)